Ameriprise’s Milestone Pharmaceuticals MIST Stock Holding History

Ameriprise’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$893K	Hold	666,666	–	–	﹤0.01%	3451
2026 Q1	$793K	Buy	+666,666	New	+$1.17M	﹤0.01%	3407

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Ameriprise's MIST Position: Q2 2026 in Review

Ameriprise held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 666,666 shares worth $893K. The position accounts for ﹤0.01% of the portfolio, ranked #3451.

Ameriprise first reported a position in MIST in Q1 2026 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Ameriprise held 666,666 shares of Milestone Pharmaceuticals worth $893K as of Q2 2026.
Ameriprise left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
Milestone Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3451 holding.
Ameriprise first reported a position in Milestone Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.